应用预防医学
應用預防醫學
응용예방의학
JOURNAL OF APPLIED PREVENTIVE MEDICINE
2012年
6期
332-335
,共4页
朱宇佳%李健龙%覃雄林%覃琼芬%吴兴华
硃宇佳%李健龍%覃雄林%覃瓊芬%吳興華
주우가%리건룡%담웅림%담경분%오흥화
获得性免疫缺陷综合征%机会性感染%多因素分析
穫得性免疫缺陷綜閤徵%機會性感染%多因素分析
획득성면역결함종합정%궤회성감염%다인소분석
Acquired immune deficiency syndrome%Opportunistic infections%Multivariate analysis
目的探讨 HIV 感染者/AIDS 患者合并机会性感染住院患者死亡的危险因素.方法用回顾性调查方法,分析和比较2006~2010年贵港市人民医院住院的322例HIV/AIDS合并机会性感染住院患者中死亡病例和存活病例的人口学资料、临床特征和实验室检查,应用多因素Logistic回归分析探讨导致患者死亡的危险因素.结果 CD4+T淋巴细胞计数≤200×106/L(X1)和抗结核治疗不规范(X3)为HIV/AIDS合并机会性感染患者死亡危险因素,X1相应统计参数 OR=9.381:1(4.939,17.818;95%CI.结论 CD4+T淋巴细胞计数与HIV/AIDS合并机会性感染患者的预后有一定的关联.
目的探討 HIV 感染者/AIDS 患者閤併機會性感染住院患者死亡的危險因素.方法用迴顧性調查方法,分析和比較2006~2010年貴港市人民醫院住院的322例HIV/AIDS閤併機會性感染住院患者中死亡病例和存活病例的人口學資料、臨床特徵和實驗室檢查,應用多因素Logistic迴歸分析探討導緻患者死亡的危險因素.結果 CD4+T淋巴細胞計數≤200×106/L(X1)和抗結覈治療不規範(X3)為HIV/AIDS閤併機會性感染患者死亡危險因素,X1相應統計參數 OR=9.381:1(4.939,17.818;95%CI.結論 CD4+T淋巴細胞計數與HIV/AIDS閤併機會性感染患者的預後有一定的關聯.
목적탐토 HIV 감염자/AIDS 환자합병궤회성감염주원환자사망적위험인소.방법용회고성조사방법,분석화비교2006~2010년귀항시인민의원주원적322례HIV/AIDS합병궤회성감염주원환자중사망병례화존활병례적인구학자료、림상특정화실험실검사,응용다인소Logistic회귀분석탐토도치환자사망적위험인소.결과 CD4+T림파세포계수≤200×106/L(X1)화항결핵치료불규범(X3)위HIV/AIDS합병궤회성감염환자사망위험인소,X1상응통계삼수 OR=9.381:1(4.939,17.818;95%CI.결론 CD4+T림파세포계수여HIV/AIDS합병궤회성감염환자적예후유일정적관련.
Objective To explore the risk factors of death from the people infected with HIV and AIDS patients in hospital with opportunistic infection. Methods Retrospective study was carried out and the demography, clinical and laboratory features of 322 patients with HIV/AIDS opportunistic infections admitted to the people’s hospital of Guigang from 2006~2010 were analyzed. Multifactorial analysis was done by using logistic regression to find the risking factors of death. Results The results of logistic regression showed that CD4+ T lymphocyte count≤200×106/L (X1)、Hb≤80g/L (X2) and non-standardized anti-TB treatment were the major risk factors of death, Conclusions There is a certain relation between CD4 + T lymphocyte count≤200×106/L (X1)、Hb≤80g/L (X2) and non-standardized anti-TB treatment and HIV/AIDS with opportunistic infection patient’s prognosis.